1-<sup>11</sup>C-Acetate as a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate Cancer
Amy L. Vāvere, Jason S. Lewis(Memorial Sloan Kettering Cancer Center)
Cited by 154
Related Papers
Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
|PLoS ONE|2010|129
Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with <sup>18</sup>F-FDG and <sup>89</sup>Zr-Trastuzumab PET
|Journal of Nuclear Medicine|2013|93
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
|Nature Communications|2022|40
Noninvasive <sup>89</sup> Zr-Transferrin PET Shows Improved Tumor Targeting Compared with <sup>18</sup> F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer
|Journal of Nuclear Medicine|2017|37
Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
|Journal of Nuclear Medicine|2019|32